logo-loader

Stryker buys K2M for US$1.4bn to strengthen grip on global spinal market

Last updated: 10:52 30 Aug 2018 EDT, First published: 10:43 30 Aug 2018 EDT

Back of a person.
Stryker is is one of the world`s leading medical technology companies.

Stryker Corp (NYSE:SYK) said on Thursday it has acquired K2M Group Holdings Inc (NASDAQ:KTWO) for around US$1.4bn, bolstering its presence in the global spinal market.

Under the deal, Stryker will acquire all shares of K2M for US$27.50 per share. 

Stryker said in a statement the combined resources of both companies will strengthen its leadership in the orthopedia and neurosurgical spine market which is worth US$10bn around the world.

READ: Stryker Corp to buy medical imaging group NOVADAQ Technologies for US$701mln

Shares of Stryker were trading on Thursday down 0.76% at US$169.96. K2M shares rallied 25.46% to US$27.36. 

Oppenheimer analyst Steven Lichtman said the deal should benefit both companies.

"We see KTWO as a good fit for SYK. KTWO provides complementary focus areas including its leading position in 3-D printed implants and strengthens SYK’s position in the deformity market where KTWO is a leading player and has stronger market share compared to its share of the broader spine market," he said.

K2M has annual sales of nearly US$300mln. The company was founded in 2004. The acquisition is expected to close in the fourth quarter of the year.

Stryker is is one of the world`s leading medical technology companies. It is based in Kalamazoo, Michigan.  

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 31 minutes ago